¢
BIZBITE

Mobile Phlebotomy Service

Blood draws on wheels for labs, trials, and homebound patients

Bottom line

Accessible entry point; validate local supply before buying.

Mobile phlebotomy companies send certified phlebotomists to homes, senior living facilities, employers, and clinical trial participants to collect blood and specimen samples. The surprising angle is that this tiny, boring service is piggybacking on the rise of home healthcare and decentralized clinical trials. Quest Diagnostics notes mobile blood draws can improve clinical trial retention by 25% and cut turnaround time by about 3 days, which makes the service far more strategic than a simple house call.

57
Acquisition score
Strong

Avg Revenue

$350K

Profit Margin

34%

Acquisition Multiple

2x - 4x

Startup Cost

$10K - $60K

How It Works

You contract with labs, physician groups, insurers, home health agencies, or research organizations that need specimen collection outside a clinic. Revenue comes from per-visit draw fees, mileage, STAT surcharges, employer wellness events, and recurring route work in senior facilities. Once dispatch and lab handoff are dialed in, the business scales by adding phlebotomists rather than expensive equipment.

Revenue Range

Low End
$120K
Typical
$350K
High End
$900K

Real Acquisitions in This Category

SBA 7(a) change-of-ownership loans · NAICS 621999 · All Other Miscellaneous Ambulatory Health Care Services

Deals tracked
13
3 in last 24 mo
Median loan
$330K
$250K–$646K p25/p75
Implied deal size
$388K
median · ~85% LTV
Charge-off rate
not enough resolved loans

Deal Size Distribution

<$150K
1
$150K–500K
8
$500K–1M
3
$1M–2M
1
>$2M
0

Financing Profile

Median rate
8.50%
33% fixed · last 24 mo
Median term
120 mo
standard 10-yr
Collateralized
0%
of loans secured
Median jobs
18
supported per deal
Top lenders in this space
Live Oak Banking Company2
Old National Bank2
Renasant Bank1
The Bancorp Bank National Association1
Wells Fargo Bank National Association1
Where deals happen
MN3
WI2
CA2
AL1
MI1
TX1
WA1
AZ1
NC1

Recent Comparable Deals

ClosedStateLoanImplied deal
Dec 2024WI$150K$177K
Dec 2024WI$712K$838K
Jun 2024MI$852K$1.0M
Apr 2024MN$250K$294K
Apr 2024MN$1.4M$1.6M
Jun 2023AZ$435K$512K
Feb 2023AL$295K$347K
Sep 2022WA$646K$760K
Sep 2021MN$59K$69K
Jun 2021CA$250K$294K
Volume rank #338/544Deal-size rank #502/544p90 loan: $712KData as of Mar 2026

Source: SBA 7(a) FOIA dataset, filtered to acquisitions (loans where business age is "Change of Ownership"). Implied deal size assumes an 85% loan-to-purchase ratio, a common SBA change-of-ownership structure. Charge-off rate shown only when 10+ loans have resolved (paid in full or charged off). Interest rates reflect last 24 months only. Actual deal values vary with equity injections, seller financing, and working capital terms.

Pros

  • +Rides the home-health and decentralized-trial trend without owning a lab
  • +Low startup cost compared with most healthcare businesses
  • +Recurring B2B relationships can stabilize volume
  • +A good dispatch network creates a real local moat

Cons

  • -Credentialing, specimen handling, and compliance matter a lot
  • -Travel inefficiency can destroy margins fast
  • -Some contracts depend on a handful of referral partners

Best For

Operators with healthcare ops experience who can manage field staff, routing, and compliance without overcomplicating it

Operating Costs

Main costs are labor, mileage, scheduling software, supplies, liability insurance, and occasional courier or cold-chain logistics. Margins improve when you cluster recurring draws by geography and win institutional accounts instead of one-off consumer jobs.

SBA Financing Estimator

Adjust the deal — see if it cash flows after debt service

+$4K/mo
after debt service
Deal price — $530K
Range: $530K (2×) to $1.8M (4×+)
Down payment — 15% ($80K)
SBA minimum equity injection is 10% for change-of-ownership
Interest rate — 8.50%
SBA median for this category: 8.5%
Loan term — 10 years (120 mo)
SBA median for this category: 120 months
Down payment
$80K
15% equity injection
Loan amount
$451K
85% SBA-financed
Monthly payment
$6K/mo
$220K total interest
Monthly profit
$10K/mo
at 34% margin
Monthly cash flow after debt service
+$4K/mo
Down payment paid back in ~19 months — strong return

Estimates only. Excludes owner compensation, capex, working capital draws, and taxes. Margin assumes average occupancy and volume. Actual SBA terms vary by lender and borrower profile.

Where to Buy

Emergen Research – North America Mobile Phlebotomy Services Market

Market overview for mobile phlebotomy and home-based specimen collection

Quest Diagnostics – Mobile Clinical Services

Evidence that mobile blood draws improve trial retention and turnaround

BizBuySell

Marketplace where healthcare service businesses periodically appear

57/100Strong

Acquisition Score

Profit margin
23/30
Entry multiple
21/25
Market depth
0/20
Risk (charge-off)
8/15
Deal momentum
5/10

Scores margin (30), entry multiple (25), SBA market depth (20), category risk (15), and deal momentum (10). Higher = better acquisition candidate.

Quick Facts

Category
service
Difficulty
3/5
Buy price
$700K$1.4M

Get the full breakdown in your inbox

Weekly boring business breakdowns

One boring business. Real numbers. Every week. Free.

Buy a mobile phlebotomy service
via Emergen Research – North America Mobile Phlebotomy Services Market
See listings →